X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11159) 11159
Publication (679) 679
Book Review (208) 208
Book Chapter (51) 51
Conference Proceeding (20) 20
Dissertation (6) 6
Magazine Article (5) 5
Data Set (2) 2
Government Document (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tolerability (10433) 10433
humans (7278) 7278
index medicus (4779) 4779
female (4627) 4627
male (4615) 4615
efficacy (4580) 4580
adult (3436) 3436
middle aged (3394) 3394
safety (3068) 3068
pharmacology & pharmacy (3051) 3051
treatment outcome (2446) 2446
aged (2409) 2409
double-blind (2381) 2381
pharmacokinetics (1682) 1682
adolescent (1550) 1550
clinical neurology (1541) 1541
double-blind method (1464) 1464
psychiatry (1333) 1333
drug therapy (1150) 1150
young adult (1013) 1013
dose-response relationship, drug (1007) 1007
care and treatment (877) 877
medicine & public health (846) 846
analysis (820) 820
medicine, general & internal (813) 813
therapy (803) 803
aged, 80 and over (781) 781
clinical trials (753) 753
child (750) 750
internal medicine (739) 739
drug therapy, combination (732) 732
neurosciences (717) 717
animals (714) 714
children (682) 682
trial (677) 677
prospective studies (674) 674
drug administration schedule (643) 643
management (625) 625
randomized controlled trials as topic (619) 619
research (618) 618
multicenter (609) 609
epilepsy (595) 595
schizophrenia (573) 573
pharmacodynamics (567) 567
time factors (556) 556
administration, oral (545) 545
dosage and administration (542) 542
retrospective studies (533) 533
placebo (531) 531
pharmacology/toxicology (527) 527
pharmacotherapy (501) 501
medicine, research & experimental (498) 498
immunology (494) 494
health aspects (490) 490
follow-up studies (488) 488
hypertension (474) 474
pharmacology (473) 473
quality of life (464) 464
oncology (447) 447
urology & nephrology (431) 431
metaanalysis (423) 423
anticonvulsants - therapeutic use (418) 418
risk factors (413) 413
open-label (410) 410
drugs (396) 396
quality-of-life (396) 396
child, preschool (394) 394
pediatrics (388) 388
pain (386) 386
neurology (385) 385
infectious diseases (380) 380
toxicology (370) 370
antipsychotic agents - therapeutic use (369) 369
cross-over studies (369) 369
placebo-controlled trial (365) 365
prevalence (363) 363
studies (363) 363
cardiac & cardiovascular systems (357) 357
severity of illness index (352) 352
patients (351) 351
medical research (348) 348
adults (343) 343
seizures (343) 343
clinical trials as topic (339) 339
antiepileptic drugs (338) 338
hypertension - drug therapy (332) 332
antipsychotic agents - adverse effects (331) 331
depression (330) 330
prevention (329) 329
antidepressants (325) 325
drug dosages (324) 324
risk (317) 317
migraine (316) 316
drug interactions (314) 314
complications and side effects (311) 311
usage (308) 308
monotherapy (301) 301
schizophrenia - drug therapy (299) 299
area under curve (287) 287
combination (282) 282
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10322) 10322
German (329) 329
Spanish (160) 160
Russian (142) 142
French (111) 111
Italian (70) 70
Polish (20) 20
Portuguese (20) 20
Turkish (19) 19
Czech (14) 14
Japanese (13) 13
Korean (8) 8
Hungarian (5) 5
Chinese (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 04/2019, Volume 125, Issue 8, pp. 1384 - 1385
Journal Article
International Journal of Clinical Pharmacology and Therapeutics, ISSN 0946-1965, 2017, Volume 55, Issue 3, pp. 231 - 236
Journal Article
Journal of Dermatological Treatment, ISSN 0954-6634, 2019, pp. 1 - 8
Topical tretinoin's role in acne has been established through evidence-based guidelines. Cutaneous irritation and potential to cause or exacerbate... 
tretinoin | Acne | tolerability | polymeric emulsion
Journal Article
International Journal of Rheumatic Diseases, ISSN 1756-1841, 04/2019, Volume 22, Issue 4, pp. 753 - 755
Journal Article
Neurology, ISSN 0028-3878, 07/2018, Volume 91, Issue 4, pp. e364 - e373
OBJECTIVETo evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for... 
CONTROLLED-TRIAL | DICLOFENAC POTASSIUM | TRIPTANS SEROTONIN | EFFICACY | HEADACHE | 5-HT1B/1D AGONISTS | TOLERABILITY | DOUBLE-BLIND | OPEN-LABEL | PREVENTION AMPP | CLINICAL NEUROLOGY | 101 | 321 | 222 | 302
Journal Article
Epilepsia, ISSN 0013-9580, 04/2018, Volume 59, Issue 4, pp. 866 - 876
Journal Article
Transplantation Proceedings, ISSN 0041-1345, 12/2018, Volume 50, Issue 10, pp. 4099 - 4101
This case describes a female patient with polyarticular tophaceous gout who was given transplant immunosuppressant medications. The 36-year-old was treated for... 
SURGERY | IMMUNOLOGY | EFFICACY | TOLERABILITY | TRANSPLANTATION
Journal Article
THORAX, ISSN 0040-6376, 06/2010, Volume 65, Issue 6, pp. 473 - 479
Background Indacaterol is a long-acting inhaled beta(2)-agonist (LABA) for the treatment of chronic obstructive pulmonary disease (COPD). In previous studies,... 
OBSTRUCTIVE PULMONARY-DISEASE | PLACEBO | CLINICAL-TRIAL | SAFETY | RESPIRATORY SYSTEM | DYSPNEA | TOLERABILITY | EXACERBATIONS | BROMIDE | INDEX | DRY POWDER
Journal Article
BRAIN, ISSN 0006-8950, 07/2019, Volume 142, Issue 7, pp. 1894 - 1904
Lasmiditan, a serotonin 5-HT1F receptor agonist, was effective for acute treatment of patients with migraine in a phase 3 double-blind randomized controlled... 
migraine | SAFETY | 5-HT1B/1D AGONISTS | PREVALENCE | NEUROSCIENCES | efficacy | CLINICAL NEUROLOGY | phase 3 | THERAPY | lasmiditan | TRIPTANS | PEOPLE | safety/tolerability | EPISODIC MIGRAINE | Clinical Trial | Editor's Choice | safety | tolerability
Journal Article
RSC Advances, ISSN 2046-2069, 2018, Volume 8, Issue 5, pp. 2768 - 2776
Prostate cancer (PCa) is a common cancer among males and a leading cause of cancer deaths. Docetaxel (DOC) was recommended in guidelines as the first... 
Journal Article
Journal of Affective Disorders, ISSN 0165-0327, 01/2020, Volume 261, pp. 259 - 270
Journal Article
SCHMERZ, ISSN 0932-433X, 04/2019, Volume 33, Issue 2, pp. 97 - 98
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 10/2019, Volume 108, Issue 10, pp. 3396 - 3407
This work aims at (1) assessing the potential of repurposing simvastatin (SV) to support the most common therapies against melanoma and (2) developing an... 
topical film | simvastatin | melanoma | nanostructured lipid carriers | topical treatment | tolerability
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 04/2019, Volume 30, Issue 4, pp. 558 - 566
Background: In the OlympiAD study, olaparib was shown to improve progression-free survival compared with chemotherapy treatment of physician's choice (TPC) in... 
germline BRCA mutation | overall survival | breast cancer | olaparib | PARP inhibitor | tolerability | ONCOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.